Key terms and concepts in clinical intelligence, evidence-based medicine, and clinical decision support. Written at a physician level by the Ailva team.
Clinical Decision Support
Clinical decision support (CDS) refers to tools and systems that provide clinicians with patient-specific, evidence-based information at the point of care to assist in clinical decision-making. Traditional CDS systems include drug interaction alerts, order sets, and guideline-based prompts within electronic health records. More recent clinical intelligence platforms like Ailva extend this concept by synthesizing evidence from millions of peer-reviewed papers and reasoning across medical specialties in response to natural-language clinical questions.
Clinical Intelligence Platform
A clinical intelligence platform is a category of clinical decision support tool that goes beyond simple information retrieval to synthesize, reason across, and contextualize medical evidence for a specific clinical scenario. Unlike static reference databases or single-specialty lookup tools, a clinical intelligence platform connects findings across organ systems and specialties. Ailva is a clinical intelligence platform that provides cross-system reasoning, patient-specific evidence synthesis, and verified citations for NPI-verified physicians.
Citation Verification
Citation verification in clinical tools is the process of confirming that every referenced paper exists, that the cited clinical claim appears in the source, and that reported effect sizes match the original data. This is critical because generative systems can produce plausible-sounding references that do not correspond to real publications. Ailva verifies every citation in every response against an index of over 5 million peer-reviewed papers before it reaches the physician. Citations that cannot be verified are automatically removed.
Cross-System Reasoning
Cross-system reasoning is the ability to trace clinical connections across multiple organ systems, specialties, and therapeutic domains within a single analysis. In practice, this means identifying that a nephrology subgroup analysis is relevant to a cardiology question, or that a drug-nutrient interaction spans endocrinology and neurology. Ailva uses cross-system reasoning to synthesize evidence from across 46 medical specialties, surfacing connections that single-specialty tools miss.
Evidence-Based Medicine
Evidence-based medicine (EBM) is the practice of integrating the best available research evidence with clinical expertise and patient values when making decisions about patient care. First formalized in the early 1990s, EBM depends on clinicians having access to current, relevant evidence. Clinical intelligence platforms support evidence-based practice by synthesizing the most relevant studies for a specific clinical question and presenting them with verified citations so physicians can evaluate the evidence directly.
Point-of-Care Evidence
Point-of-care evidence refers to clinical information that is available to a physician at the time and place where patient care decisions are being made. The value of clinical evidence depends heavily on its accessibility in the moment it is needed. Ailva is designed as a point-of-care clinical intelligence platform, delivering evidence-based answers with verified citations in seconds for simple queries and under a minute for complex multi-system cases.
Patient-Specific Evidence
Patient-specific evidence is clinical data drawn from subgroup analyses, post-hoc analyses, and trial populations that match the demographic and comorbidity profile of a particular patient. Generic guideline summaries may not account for the combined effect of multiple conditions. Ailva identifies and surfaces subgroup data relevant to the specific patient profile described in a clinical question, providing more actionable evidence than broad recommendations alone.
Subgroup Analysis
A subgroup analysis examines the treatment effect within a defined subset of a clinical trial population, such as patients over age 65, patients with renal impairment, or patients with specific comorbidities. Subgroup analyses are valuable for determining whether a treatment benefit observed in the overall trial population applies to a particular patient profile. Ailva surfaces relevant subgroup data when a clinical question describes a specific patient, citing the original trial and subgroup study.
NPI Verification
NPI verification is the process of confirming that a user holds a valid National Provider Identifier, a unique 10-digit number assigned to healthcare providers in the United States by the Centers for Medicare and Medicaid Services. Ailva uses NPI verification to ensure that only licensed US healthcare professionals — including MDs, DOs, NPs, PAs, and PharmDs — can access the platform. This verification protects the integrity of the clinical environment and ensures content is used by qualified clinicians.
Medical Literature Synthesis
Medical literature synthesis is the process of combining findings from multiple clinical studies into a coherent analysis that addresses a specific clinical question. Unlike systematic reviews, which follow a predefined protocol over months, clinical intelligence tools like Ailva perform real-time synthesis by searching across millions of indexed papers, identifying the most relevant evidence, and presenting a unified answer with verified citations. This synthesis spans specialties and study types, including RCTs, meta-analyses, cohort studies, and guideline documents.
Hallucinated Citations
Hallucinated citations are fabricated or incorrect references produced by generative systems that appear plausible but do not correspond to real published studies. A hallucinated citation may have a real-sounding author name, journal title, and year but reference a paper that does not exist or does not support the stated claim. Ailva addresses this problem through mandatory citation verification: every citation is checked against indexed peer-reviewed literature before delivery, and any citation that cannot be verified is removed from the response.
Bench-to-Bedside Gap
The bench-to-bedside gap refers to the delay between when clinical research produces actionable findings and when those findings are adopted into routine medical practice. A widely cited 2001 study by Balas and Boren estimated this gap at an average of 17 years. During that interval, patients who could benefit from published evidence may not receive it. Clinical intelligence platforms like Ailva aim to compress this gap by giving physicians immediate access to synthesized, current evidence at the point of care.
Evidence Fragmentation
Evidence fragmentation describes the state in which clinically relevant findings are scattered across thousands of journals, multiple specialties, and different study types with no single source that integrates them. A cardiologist may not routinely read nephrology journals, yet a nephrology trial may contain subgroup data directly relevant to a cardiology patient. Ailva addresses evidence fragmentation by searching across all indexed specialties simultaneously and synthesizing findings into a single, cross-system clinical answer.
Multi-System Clinical Reasoning
Multi-system clinical reasoning is the process of considering how conditions, treatments, and evidence across multiple organ systems interact in a single patient. Patients with comorbidities often receive recommendations from multiple specialists that may conflict. Multi-system reasoning resolves these conflicts by evaluating the combined evidence across all relevant systems. Ailva performs multi-system clinical reasoning by synthesizing evidence from cardiology, nephrology, endocrinology, and 43 other specialties in a single response.
Clinical Evidence Grading
Clinical evidence grading is a system for classifying the strength and quality of evidence supporting a clinical recommendation. Common frameworks include the ACC/AHA classification (Class I-III with Levels of Evidence A-C) and the GRADE system. Evidence grading helps physicians assess how much confidence to place in a recommendation. Ailva identifies the study design and evidence level of each cited source — including whether it is a randomized controlled trial, meta-analysis, cohort study, or guideline recommendation — so physicians can evaluate evidence strength at a glance.
Clinical Query
A clinical query is a question posed by a healthcare professional about a specific patient scenario, drug interaction, treatment protocol, or diagnostic approach. Clinical queries range from simple lookups (first-line treatment, drug dosing) to complex multi-system cases involving competing specialist recommendations. Ailva accepts clinical queries in natural language, allowing physicians to ask questions the way they would consult a colleague rather than using structured search syntax.
Verified Clinical Response
A verified clinical response is an evidence-based answer to a clinical query in which every factual claim is supported by a citation that has been confirmed against indexed peer-reviewed literature. Verification ensures that the cited paper exists, that the claim appears in the source, and that reported data matches the original publication. Ailva delivers verified clinical responses as its standard output, with no option to bypass the verification process.